SOPHiA GENETICS SA - Ordinary Shares, CHF 0.05 per share (SOPH)

CUSIP: H82027105

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Ordinary Shares, CHF 0.05 per share
Shares outstanding
67,372,245
Total 13F shares
17,242,483
Share change
+304,259
Total reported value
$81,215,514
Put/Call ratio
0%
Price per share
$4.71
Number of holders
36
Value change
+$1,537,473
Number of buys
15
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP H82027105?
CUSIP H82027105 identifies SOPH - SOPHiA GENETICS SA - Ordinary Shares, CHF 0.05 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SOPHiA GENETICS SA - Ordinary Shares, CHF 0.05 per share (SOPH) as of Q4 2023

As of 31 Dec 2023, SOPHiA GENETICS SA - Ordinary Shares, CHF 0.05 per share (SOPH) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,242,483 shares. The largest 10 holders included GENERATION INVESTMENT MANAGEMENT LLP, BANQUE PICTET & CIE SA, CREDIT SUISSE AG/, MILLENNIUM MANAGEMENT LLC, Alta Wealth Advisors LLC, PRINCIPAL FINANCIAL GROUP INC, BlackRock Inc., PURA VIDA INVESTMENTS, LLC, Bank Pictet & Cie (Europe) AG, and Parkman Healthcare Partners LLC. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.